Live Breaking News & Updates on Heisenberg Programme

Stay updated with breaking news from Heisenberg programme. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Coronavirus vaccine demonstrates the long-term value of knowledge-driven basic research


 E-Mail
The most promising vaccine against the coronavirus to date is also an example of the long-term value of curiosity-driven basic research and its funding by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation). The so-called mRNA vaccine platform, which the Mainz-based company BioNTech uses in its Covid-19 vaccine developed jointly with the US pharmaceutical company Pfizer, can be traced back to preliminary work carried out from 2006 to 2008 in a project within a DFG-funded Collaborative Research Centre (CRC) on cancer research at the Johannes Gutenberg University Mainz. This in turn was also tied to previous DFG-funded research.
The project was led by the later founder and current CEO of BioNTech, Professor Dr. U?ur ?ahin, whose name and person are closely associated with the development of the BNT162b2 vaccine, which will be deployed immediately following its approval in the United Kingdom and its anticipated approval in the USA and the EU. In ad ....

United States , United Kingdom , Tobias Grimm , Deutschen Wissenschaft , Katja Becker , Christoph Huber , Christian Drosten , Hans Georg Rammensee , Ingmar Hoerr , Deutsche Forschungsgemeinschaft , Marco Finetti , Head Office , Collaborative Research Centres , Mainz University Medical Centre , Priority Programme , Research Training Group , Research Matters , University Of Mainz , Johannes Gutenberg University Mainz , German Federal Ministry Of Education , Commission For Pandemic Research , Collaborative Research Centre , Clinical Research Unit , German Research Foundation , Heisenberg Programme , Head Of Life Sciences ,